Scan this study, as I think it could provide the answer to your question, or at least a clue. Note that this study is built on the large amount of lab work with monepantel on human cancers at the ONJCRI (led by Dr Fairlea).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315739/
Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-127
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $97.22M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $95.38K | 475.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 136756 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 79851 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |